217 related articles for article (PubMed ID: 21527942)
1. Tubular biomarkers to assess progression of diabetic nephropathy.
Tramonti G; Kanwar YS
Kidney Int; 2011 May; 79(10):1042-4. PubMed ID: 21527942
[TBL] [Abstract][Full Text] [Related]
2. Tubular markers do not predict the decline in glomerular filtration rate in type 1 diabetic patients with overt nephropathy.
Nielsen SE; Andersen S; Zdunek D; Hess G; Parving HH; Rossing P
Kidney Int; 2011 May; 79(10):1113-8. PubMed ID: 21270761
[TBL] [Abstract][Full Text] [Related]
3. Nonalbuminuric proteinuria as a biomarker for tubular damage in early development of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Kim WJ; Jeon YK; Kim BH; Kwak IS; Lee EK; Kim YK
Diabetes Metab Res Rev; 2014 Nov; 30(8):736-41. PubMed ID: 24687388
[TBL] [Abstract][Full Text] [Related]
4. Assessment of kidney function in diabetic patients. Is there a role for new biomarkers NGAL, cystatin C and KIM-1?
Matys U; Bachorzewska-Gajewska H; Malyszko J; Dobrzycki S
Adv Med Sci; 2013; 58(2):353-61. PubMed ID: 24384771
[TBL] [Abstract][Full Text] [Related]
5. Clinical implication of urinary tubular markers in the early stage of nephropathy with type 2 diabetic patients.
Kim SS; Song SH; Kim IJ; Yang JY; Lee JG; Kwak IS; Kim YK
Diabetes Res Clin Pract; 2012 Aug; 97(2):251-7. PubMed ID: 22440044
[TBL] [Abstract][Full Text] [Related]
6. Review and discussion of tubular biomarkers in the diagnosis and management of diabetic nephropathy.
Tramonti G; Kanwar YS
Endocrine; 2013 Jun; 43(3):494-503. PubMed ID: 23086402
[TBL] [Abstract][Full Text] [Related]
7. [Evaluation of tubulointerstitial injury by new biomarkers].
Mori K; Mukoyama M; Kasahara M; Nakao K
Nihon Jinzo Gakkai Shi; 2011; 53(4):596-9. PubMed ID: 21688478
[No Abstract] [Full Text] [Related]
8. A progression in peritubular capillary flow reduction and tubulointerstitial fibrosis reflected by FE Mg predict the decline in glomerular filtration rate.
Futrakul N; Futrakul P
Kidney Int; 2012 Apr; 81(7):707; author reply 707. PubMed ID: 22419044
[No Abstract] [Full Text] [Related]
9. NGAL, L-FABP, and KIM-1 in comparison to established markers of renal dysfunction.
Holzscheiter L; Beck C; Rutz S; Manuilova E; Domke I; Guder WG; Hofmann W
Clin Chem Lab Med; 2014 Apr; 52(4):537-46. PubMed ID: 24243749
[TBL] [Abstract][Full Text] [Related]
10. High urinary excretion of kidney injury molecule-1 is an independent predictor of end-stage renal disease in patients with IgA nephropathy.
Peters HP; Waanders F; Meijer E; van den Brand J; Steenbergen EJ; van Goor H; Wetzels JF
Nephrol Dial Transplant; 2011 Nov; 26(11):3581-8. PubMed ID: 21467131
[TBL] [Abstract][Full Text] [Related]
11. Changes of the tubular markers in type 2 diabetes mellitus with glomerular hyperfiltration.
Fu WJ; Li BL; Wang SB; Chen ML; Deng RT; Ye CQ; Liu L; Fang AJ; Xiong SL; Wen S; Tang HH; Chen ZX; Huang ZH; Peng LF; Zheng L; Wang Q
Diabetes Res Clin Pract; 2012 Jan; 95(1):105-9. PubMed ID: 22015481
[TBL] [Abstract][Full Text] [Related]
12. [Early biomarker for AKI].
Mori K; Mukoyama M; Nakao K
Nihon Jinzo Gakkai Shi; 2010; 52(5):566-71. PubMed ID: 20715588
[No Abstract] [Full Text] [Related]
13. Renal tubular markers in pregnant women with and without gestational diabetes mellitus: a pilot study.
Fu WJ; Deng RT; Huang ZH; Chen ML; Wang DJ; Jiang YM; Wen S; Yang HL; Huang XZ
Endocrine; 2015 Jun; 49(2):563-5. PubMed ID: 25539794
[No Abstract] [Full Text] [Related]
14. Biomarkers of renal function, which and when?
Wasung ME; Chawla LS; Madero M
Clin Chim Acta; 2015 Jan; 438():350-7. PubMed ID: 25195004
[TBL] [Abstract][Full Text] [Related]
15. Urinary tubular biomarkers in short-term type 2 diabetes mellitus patients: a cross-sectional study.
Fu WJ; Xiong SL; Fang YG; Wen S; Chen ML; Deng RT; Zheng L; Wang SB; Pen LF; Wang Q
Endocrine; 2012 Feb; 41(1):82-8. PubMed ID: 21779943
[TBL] [Abstract][Full Text] [Related]
16. Biomarkers for early detection of sickle nephropathy.
Sundaram N; Bennett M; Wilhelm J; Kim MO; Atweh G; Devarajan P; Malik P
Am J Hematol; 2011 Jul; 86(7):559-66. PubMed ID: 21630304
[TBL] [Abstract][Full Text] [Related]
17. Glomerular and tubular damage markers are elevated in patients with diabetes.
Nauta FL; Boertien WE; Bakker SJ; van Goor H; van Oeveren W; de Jong PE; Bilo H; Gansevoort RT
Diabetes Care; 2011 Apr; 34(4):975-81. PubMed ID: 21307379
[TBL] [Abstract][Full Text] [Related]
18. The effect of RAAS blockade on markers of renal tubular damage in diabetic nephropathy: u-NGAL, u-KIM1 and u-LFABP.
Nielsen SE; Rossing K; Hess G; Zdunek D; Jensen BR; Parving HH; Rossing P
Scand J Clin Lab Invest; 2012 Apr; 72(2):137-42. PubMed ID: 22268365
[TBL] [Abstract][Full Text] [Related]
19. Role of new biomarkers for predicting renal scarring in vesicoureteral reflux: NGAL, KIM-1, and L-FABP.
Parmaksız G; Noyan A; Dursun H; İnce E; Anarat R; Cengiz N
Pediatr Nephrol; 2016 Jan; 31(1):97-103. PubMed ID: 26324091
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril.
Nielsen SE; Schjoedt KJ; Astrup AS; Tarnow L; Lajer M; Hansen PR; Parving HH; Rossing P
Diabet Med; 2010 Oct; 27(10):1144-50. PubMed ID: 20854382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
